Solana News: Cboe’s Bold Move for Staked Injective ETF Could Reshape Crypto Markets

Solana news highlights Cboe's staked Injective ETF filing with SEC

In a groundbreaking development for cryptocurrency investors, the Chicago Board Options Exchange (Cboe) has filed to list a staked Injective (INJ) ETF, potentially marking the third U.S. staking fund after Solana and Ether. This move could revolutionize how traditional investors engage with crypto staking.

What Does the Staked Injective ETF Mean for Crypto Investors?

The proposed ETF by Canary Capital aims to provide regulated exposure to Injective’s governance token while offering staking rewards. Key benefits include:

  • Structured passive income through staking
  • Regulated access to INJ tokens
  • Potential boost to Injective’s liquidity

SEC’s Evolving Stance on Crypto Staking

The May 2025 SEC clarification that staking doesn’t constitute a securities violation has opened doors for products like this ETF. However, approval could take until March 2026, with the SEC maintaining cautious oversight.

Market Reactions to Previous Crypto ETFs

ETFInitial ImpactCurrent Status
Bitcoin Spot ETFPrice surge above $50KStable growth
Ethereum Spot ETF38% price dropRecovering
Solana Staking ETFModerate gainsSteady performance

INJ Token Performance and Future Outlook

From its $52 peak in March 2024, INJ has corrected to $15.10. The ETF could stimulate demand, but market sentiment remains crucial. Analysts suggest watching:

  • SEC approval timeline
  • On-chain activity metrics
  • Broader crypto market trends

FAQs About the Staked Injective ETF

Q: When might the SEC approve the Injective ETF?
A: The review could extend to March 2026, with decisions typically coming 30-45 days after acknowledgment.

Q: How does staking work in an ETF?
A: The fund manager stakes the underlying tokens, distributing rewards to shareholders after fees.

Q: What risks come with staked crypto ETFs?
A: Volatility, regulatory changes, and staking penalties are key considerations.

Q: How does this compare to Solana’s staking ETF?
A: Both offer staking rewards, but Injective’s smaller market cap may mean higher volatility.